CANADIAN NETWORK FOR IMPROVED OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS "CANIOS" - WINNIPEG MB CANADA


Company Information

Canadian Network For Improved Outcomes In Systemic Lupus Erythematosus "CaNIOS" is a company from WINNIPEG MB Canada. The company has corporate status: Active.

CANADIAN NETWORK FOR IMPROVED OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS "CANIOS" - WINNIPEG MB CANADA

523382

Canadian Network For Improved Outcomes In Systemic Lupus Erythematosus "CaNIOS" is governed under the Canada Not-for-profit Corporations Act - 2014-12-18. It a company of type: Non-Soliciting.
The date of the company's last Annual Meeting is 2023-02-08.
The status of its annual filings are: 2024 - Not due, 2023 -Filed, 2022 -Filed.
This company has had the following names:
  • Canadian Network For Improved Outcomes In Systemic Lupus Erythematosus "CaNIOS" - 2014-12-18 to Present
  • Canadian Network For Improved Outcomes In Systemic Lupus Erythematosus "CaNIOS" - 2009-02-26to 2014-12-18
Canadian Network For Improved Outcomes In Systemic Lupus Erythematosus "CaNIOS" has between 6 and 6 directors.

Address & Map

RR149-800 SHERBROOK STREET WINNIPEG MB R3A 1M4, Canada

Company Officers

Name Address Town Country
JANET POPE 268 GROSVENOR STREET, ST. JOSEPH HEALTH CARE LONDON ON N6A 4V2 Canada
JAN DUTZ 835 WEST 19TH AVE, SKIN CARE CENTER VANCOUVER BC V5Z 4E8 Canada
DEBORAH LEVY 555 UNIVERSITY AVENUE, HOSPITAL FOR SICK CHILDREN TORONTO ON M5G 1X8 Canada
CHRISTINE PESCHKEN RR149-800 SHERBROOK STREET, HEALTH SCIENCES CENTRE REHABILITATION HO WINNIPEG MB R3A 1M4 Canada
PAUL FORTIN 2705 BOULEVARD LAURIER, LOCAL S-763, CENTRE DE RECHERCHE DU CHUQ-CHUL QUÉBEC QC G1V 4G2 Canada
STEPHANIE KEELING 562 HERITAGE RESEARCH CENTER EDMONTON AB T6G 2S2 Canada

Related Companies

Name Address Town Country Status
Canadian Scleroderma Research Group 702-25 Charlton Avenue East Hamilton ON, L9H 5E3 Canada Active
CANADIAN RHEUMATOLOGY RESEARCH CONSORTIUM 60 MURRAY ST., ROOM 2-006, BOX 4 TORONTO ON, M5T 3L9 Canada Dissolved by the corporation (s. 220)on 2024-04-11